Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Clinical Oral Investigations
Erschienen in: Clinical Oral Investigations 6/2015

01.07.2015 | Original Article

Stage-related treatment concept of medication-related osteonecrosis of the jaw—a case series

verfasst von: Petra Rugani, Stephan Acham, Barbara Kirnbauer, Astrid Truschnegg, Barbara Obermayer-Pietsch, Norbert Jakse

Erschienen in: Clinical Oral Investigations | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

There is no general consensus for treatment of medication-related osteonecrosis of the jaw (MRONJ). A stage-related approach that primarily aims to minimize morbidity and preserve function was prospectively evaluated.

Patients and methods

Treatment goals are stable mucosal closure and absence of clinical symptoms. Patients were enrolled between March 2010 and October 2011. MRONJ lesions were treated either by conservative means or surgically by debridement or resective surgery.

Results

In total, 38 patients were treated. Six patients were healed by undergoing conservative measures; nine were treated palliatively. Four patients dropped out after surgery in the recall phase. In 17 of 19 patients (89.5 %) surgical treatment was successful. After a 1-year observation period, the success rate was 92 % (23 of 25), including all patients treated as per protocol.

Conclusion

In stage-related treatment, conservative means or surgical debridement can be successful at early stages. Extensive resection is solely indicated in cases of extended necrosis.

Clinical relevance

The number of patients with MRONJ is steadily increasing. Guidelines to deal with this condition are helpful for both clinicians and dental practitioners.
Literatur
1.
Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72:1938PubMedCrossRef
2.
Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Maxillofacial Surg: Off J Am Assoc Oral Maxillofacial Surgeons 63(11):1567–1575CrossRef
3.
Suleman YF, Meer S, Lurie R (2007) Bisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report. Head Neck Pathol 1(2):156–164PubMedCentralPubMedCrossRef
4.
Nicolatou-Galitis O, Migkou M, Psyrri A et al (2012) Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications. Oral Surg, Oral Med, Oral Pathol Oral Radiol 113(2):234–238CrossRef
5.
Ruggiero S, Gralow J, Marx RE et al (2006) Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract / Am Soc Clin Oncol 2(1):7–14CrossRef
6.
Ruggiero SL, Fantasia J, Carlson E (2006) Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endodontics 102(4):433–441CrossRef
7.
Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 136(12):1658–1668PubMedCrossRef
8.
Dickinson M, Prince HM, Kirsa S et al (2009) Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment. Int Med J 39(5):304–316CrossRef
9.
Weitzman R, Sauter N, Eriksen EF et al (2007) Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients—May 2006. Crit Rev Oncol/Hematol 62(2):148–152CrossRef
10.
Abu-Id MH, Warnke PH, Gottschalk J et al (2008) “Bis-phossy jaws”—high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Cranio-Maxillo- Facial Surg: Off Publ Eur Assoc Cranio-Maxillo-Facial Surgery 36(2):95–103CrossRef
11.
Carlson ER, Basile JD (2009) Off J Am Assoc Oral Maxillofacial Surg 67(5 Suppl):85–95CrossRef
12.
Bedogni A, Saia G, Bettini G et al (2011) Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis. Oral Oncol 47(5):420–424PubMedCrossRef
13.
Biasotto M, Chiandussi S, Dore F et al (2006) Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws. Acta Odontol Scand 64(6):348–354PubMedCrossRef
14.
Badros A, Weikel D, Salama A et al (2006) Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol Off J Am Soc Clin Oncol 24(6):945–952CrossRef
15.
16.
Rugani P, Acham S, Truschnegg A, Obermayer-Pietsch B, Jakse N (2010) Bisphosphonate-associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report. Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endodontics 110(6):e1–6CrossRef
17.
Filleul O, Crompot E, Saussez S (2010) Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 136(8):1117–1124PubMedCrossRef
18.
Scoletta M, Arduino PG, Dalmasso P, Broccoletti R, Mozzati M (2010) Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study. Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endodontics 110(1):46–53CrossRef
19.
20.
Pires FR, Miranda A, Cardoso ES et al (2005) Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy. Oral Dis 11(6):365–369PubMedCrossRef
21.
Abu-Id MH, Acil Y, Gottschalk J, Kreusch T (2006) Bisphosphonate-associated osteonecrosis of the jaw. Mund-, Kiefer- Und Gesichtschirurgie: MKG 10(2):73–81PubMedCrossRef
22.
Zarychanski R, Elphee E, Walton P, Johnston J (2006) Osteonecrosis of the jaw associated with pamidronate therapy. Am J Hematol 81(1):73–75PubMedCrossRef
23.
Bagan J, Blade J, Cozar JM et al (2007) Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. Med Oral Patologia oral y Cirugia Bucal 12(4):E336–40
24.
Cheng A, Mavrokokki A, Carter G et al (2005) The dental implications of bisphosphonates and bone disease. Aust Dent J 50(4 Suppl 2):4–13CrossRef
25.
Williamson RA (2010) Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg 39(3):251–255PubMedCrossRef
26.
Diego R, D'Orto O, Pagani D et al (2007) Bisphosphonate-associated osteonecrosis of the jaws: a therapeutic dilemma. Oral Surg Oral Med Oral Pathol, Oral Radiol Endodontics 103(3):e1–5CrossRef
27.
Van den Wyngaert T, Claeys T, Huizing MT, Vermorken JB, Fossion E (2009) Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann Oncology: Off J Eur Soc Med Oncol / ESMO 20(2):331–336CrossRef
28.
Atalay B, Yalcin S, Emes Y et al (2011) Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery? Lasers Med Sci 26(6):815–823PubMedCrossRef
29.
Freiberger JJ, Padilla-Burgos R, McGraw T et al (2012) What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics. J Oral Maxillofacial Surg: Off J Am Assoc Oral Maxillofacial Surg 70(7):1573–1583CrossRef
30.
Magopoulos C, Karakinaris G, Telioudis Z et al (2007) Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Am J Otolaryngol 28(3):158–163PubMedCrossRef
31.
Mignogna MD, Fedele S, Lo Russo L, Ciccarelli R, Lo ML (2006) Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy. J Clin Oncol: Off J Am Soc Clin Oncol 24(9):1475–1477CrossRef
32.
Perez SB, Barrero MV, Hernandez MS, Knezevic M, Navarro JM, Millares JR (2008) Bisphosphonate-associated osteonecrosis of the jaw. A proposal for conservative treatment. Med Oral, Patologia Oral y Cirugia Bucal 13(12):E770–3
33.
Curi MM, Cossolin GS, Koga DH et al (2011) Bisphosphonate-related osteonecrosis of the jaws—an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma. J Oral Maxillofacial Surg: Off J Am Assoc Oral Maxillofacial Surg 69(9):2465–2472CrossRef
34.
Lee CY, David T, Nishime M (2007) Use of platelet-rich plasma in the management of oral biphosphonate-associated osteonecrosis of the jaw: a report of 2 cases. J Oral Implantol 33(6):371–382PubMedCrossRef
35.
Agrillo A, Ungari C, Filliaci F, Priore P, Iannetti G (2007) Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis. J Craniofacial Surg 18(5):1071–1075CrossRef
36.
Rugani P, Truschnegg A, Acham S, Kirnbauer B, Jakse N (2013) Use of photodynamic therapy in treatment of bisphosphonate-related osteonecrosis of the jaws: literature review and case series. J Anal Bioanal Tech S1:006. doi:10.​4172/​2155-9872.​S1-006
37.
Harper RP, Fung E (2007) Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1–34)]. J Oral Maxillofacial Surgery: Off J Am Assoc Oral Maxillofacial Surg 65(3):573–580CrossRef
38.
Mücke T, Koschinski J, Deppe H et al (2011) Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws. J Cancer Res Clin Oncol 137(5):907–13. doi:10.​1007/​s00432-010-0953-1, Epub 2010 Oct 7PubMedCrossRef
39.
Wilde F, Heufelder M, Winter K et al (2011) The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. Oral Surgery, Oral Med, Oral Pathol, Oral Radiol Endodontics 111(2):153–163CrossRef
40.
Alons K, Kuijpers SC, De Jong E, Van Merkesteyn JP (2009) Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases. Oral Surgery, Oral Med, Oral Pathol, Oral Radiol Endodontics 107(2):e1–7CrossRef
41.
Stockmann P, Vairaktaris E, Werhan F et al (2010) Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up. Supportive Care Cancer: Off J Multinational Assoc Supportive Care Cancer 18(4):449–460CrossRef
42.
Fleisher KE, Doty S, Kottal S, Phelan J, Norman RG, Glickman RS (2008) Tetracycline-guided debridement and cone beam computed tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: a technical note. J Oral Maxillofacial Surgery: Off J Am Assoc Oral Maxillofacial Surg 66(12):2646–2653CrossRef
43.
Dannemann C, Grätz KW, Zwahlen RA (2008) Bisphosphonate-induced osteonecrosis of the jaws—a guide to diagnosis, therapy and prevention of BON in dental practice. Schweiz Monatsschr Zahnmed 118:113–123PubMed
44.
45.
46.
O'Ryan FS, Khoury S, Liao W, Han MM, Hui RL, Baer D, Martin D, Liberty D, Lo JC (2009) Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. J Oral Maxillofac Surg 67(7):1363–72. doi:10.​1016/​j.​joms.​2009.​03.​005 PubMedCrossRef
47.
48.
Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J, Kreutzer K, Hohlweg-Majert B, Wolff KD, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum SR, Kolk A (2011) Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. J Oral Maxillofac Surg 69(1):84–91. doi:10.​1016/​j.​joms.​2010.​07.​014, Epub 2010 Oct 25PubMedCrossRef
49.
50.
Seth R, Futran ND, Alam DS, Knott PD (2010) Outcomes of vascularized bone graft reconstruction of the mandible in bisphosphonate-related osteonecrosis of the jaws. Laryngoscope 120(11):2165–71. doi:10.​1002/​lary.​21062 PubMedCrossRef
51.
Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayianni A, Kyrtsonis MC, Repousis P, Barbounis V, Migliorati CA (2011) Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(2):195–202. doi:10.​1016/​j.​tripleo.​2011.​02.​037, Epub 2011 May 31PubMedCrossRef
Metadaten
Titel
Stage-related treatment concept of medication-related osteonecrosis of the jaw—a case series
verfasst von
Petra Rugani
Stephan Acham
Barbara Kirnbauer
Astrid Truschnegg
Barbara Obermayer-Pietsch
Norbert Jakse
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 6/2015
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-014-1384-1

Weitere Artikel der Ausgabe 6/2015

Clinical Oral Investigations 6/2015 Zur Ausgabe

Original Article

The relationship between resting arterial blood pressure and oral postsurgical pain

Original Article

Increased periodontal inflammation in women with preterm premature rupture of membranes

Original Article

A new three-component formulation for the efficient whitening of teeth (Carbamide Plus)

Original Article

Nitric oxide-mediated cytotoxic effect induced by zoledronic acid treatment on human gingival fibroblasts

Original Article

Fluoride varnishes containing calcium glycerophosphate: fluoride uptake and the effect on in vitro enamel erosion

Original Article

Template-guided vs. non-guided drilling in site preparation of dental implants

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise